MGCLF Stock - MGC Pharmaceuticals Limited
Unlock GoAI Insights for MGCLF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $3.39M | $4.73M | $3.00M | $2.08M | $656,237 |
| Gross Profit | $1.29M | $1.56M | $736,492 | $-306,000 | $299,595 |
| Gross Margin | 38.0% | 33.0% | 24.6% | -14.7% | 45.7% |
| Operating Income | $-15,493,000 | $-15,499,000 | $-11,939,000 | $-11,805,000 | $-8,712,000 |
| Net Income | $-20,824,000 | $-20,347,000 | $-15,870,000 | $-19,363,000 | $-11,009,000 |
| Net Margin | -614.6% | -430.0% | -529.7% | -931.4% | -1677.6% |
| EPS | $-7.10 | $-7.90 | $-8.30 | $-14.00 | $-9.11 |
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.
Visit WebsiteEarnings History & Surprises
MGCLFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Nov 29, 2024 | — | — | — | — |
Q3 2024 | Jul 26, 2024 | — | — | — | — |
Q2 2024 | Apr 30, 2024 | — | — | — | — |
Q1 2024 | Feb 29, 2024 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-2.17 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-2.59 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-3.25 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-2.39 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-3.40 | — | — |
Q4 2020 | Dec 30, 2020 | — | $-2.91 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-3.47 | — | — |
Q4 2019 | Dec 30, 2019 | — | $-6.33 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-1.71 | — | — |
Q4 2018 | Dec 30, 2018 | — | $-3.11 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.80 | — | — |
Q4 2017 | Dec 30, 2017 | — | $-4.93 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-3.94 | — | — |
Q4 2016 | Dec 30, 2016 | — | $-2.30 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-2.87 | — | — |
Latest News
Frequently Asked Questions about MGCLF
What is MGCLF's current stock price?
What is the analyst price target for MGCLF?
What sector is MGC Pharmaceuticals Limited in?
What is MGCLF's market cap?
Does MGCLF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MGCLF for comparison